CancerBlood disorders

Dx dialogues: how AI might be used in the R/R AML space

Naval Daver, MD, discusses how AI might be implemented in the identification, treatment, and management of R/R AML.

LearnCancerLeukemiaDx dialogues: how AI might be used in the R/R AML space

Up Next

  • Dx dialogues: using NGS data to develop MRD assessment techniques for R/R AML

  • Dx dialogues: using molecular profiling to identify mutations in R/R AML

  • Dx dialogues: how AI might be implemented in the diagnosis and care of metastatic breast cancer

  • Dx dialogues: versatile treatment options across the multiple myeloma landscape

  • Dx dialogues: why staying current with technology is critical in oncology

  • Dx dialogues: helping physicians identify patients for combination therapies with CAR-T

  • Dx dialogues: the future of personalized ovarian response prediction

  • Dx dialogues: the impact of next-generation sequencing on clinical utility

  • Dx dialogues: identifying patients with cutaneous melanoma for TIL therapy

  • Dx dialogues: other potential treatments for indolent systemic mastocytosis

Up Next

  • Dx dialogues: using NGS data to develop MRD assessment techniques for R/R AML

  • Dx dialogues: using molecular profiling to identify mutations in R/R AML

  • Dx dialogues: how AI might be implemented in the diagnosis and care of metastatic breast cancer

  • Dx dialogues: versatile treatment options across the multiple myeloma landscape

  • Dx dialogues: why staying current with technology is critical in oncology

  • Dx dialogues: helping physicians identify patients for combination therapies with CAR-T

  • Dx dialogues: the future of personalized ovarian response prediction

  • Dx dialogues: the impact of next-generation sequencing on clinical utility

  • Dx dialogues: identifying patients with cutaneous melanoma for TIL therapy

  • Dx dialogues: other potential treatments for indolent systemic mastocytosis

AskMDAskMD

Want to learn about Cancer?

Get instant answers from our AI health assistant

Ask Now

Recommended for you

An overview of the therapies used when acute myeloid leukemia (AML) doesn’t respond to treatment or comes back after treatment.

What to know about treatment for recurrent/refractory AML
Article

Identifying gene mutations is an important step in diagnosing AML and determining the best approach to treatment.

5 answers about molecular testing and acute myeloid leukemia
Article

What to ask your cancer care team when starting any new treatment for a desmoid tumor, including medications and surgery.

What to ask when starting treatment for a desmoid tumor
Article

An overview of therapies used to treat desmoid tumors, including active surveillance, targeted therapies, and surgery.

How are desmoid tumors treated?
Article

Desmoid tumors are noncancerous and do not metastasize, but they can invade nearby tissues and structures.

Why desmoid tumors are considered aggressive
Article
AskMDHow can I be more consistent?
AskMD by Sharecare LogoAskMD by Sharecare Logo
Privacy policyConsumer health data privacyTerms of use
Cookie policyYour privacy choices

© 2026 Sharecare, Inc.

ask-mdask-md
AskMD by Sharecare LogoAskMD by Sharecare Logo
Privacy policyConsumer health data privacyTerms of use
Cookie policyYour privacy choices

© 2026 Sharecare, Inc.